Updates on Treatment of Asthma
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
5/3/2023: 12:00 AM
Ends On:
5/5/2025: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.75
Description:
Speaker:
Tiffany Biason Dy, MD
Assistant Professor of Medicine
Division of Allergy and Immunology
Disclosures: None
Planning Committee:
William B. Call, PharmD., BCPS
Clinical Supervisor, Medicine & Sub-specialties
Program Director, PGY2 Internal Medicine Pharmacy Residency
Clinical Pharmacy Specialist, Internal Medicine
Barnes-Jewish Hospital
Disclosures: None
Kristina C. Skinner, MSN, FNP-C
Nurse Practitioner, Allergy & Immunology
Division of Allergy and Immunology
Disclosures: None
Speaker:
Tiffany Biason Dy, MD
Assistant Professor of Medicine
Division of Allergy and Immunology
Disclosures: None
Planning Committee:
William B. Call, PharmD., BCPS
Clinical Supervisor, Medicine & Sub-specialties
Program Director, PGY2 Internal Medicine Pharmacy Residency
Clinical Pharmacy Specialist, Internal Medicine
Barnes-Jewish Hospital
Disclosures: None
Kristina C. Skinner, MSN, FNP-C
Nurse Practitioner, Allergy & Immunology
Division of Allergy and Immunology
Disclosures: None
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Diagnose patients with persistent asthma and recommend SMART therapy if applicable, based on 2020 NAEPP Asthma Update Guidelines
- Counsel patients regarding the use of a single inhaler for both maintenance and rescue treatment
- Anticipate and plan for potential barriers to implementation of SMART
Additional Information:
Target Audience: This course is designed for physicians, nurses, nurse practitioners and pharmacists who specialize in adult endocrinology, internal medicine, family & general practice, and hospital medicine. The intended goal of this activity is increased knowledge, competence and performance and enhanced patient care.
Publication Date: May 3, 2023
Expiration Date: May 5, 2023
This presentation originated from the "Updates in Clinical Allergy & Immunology" course held August 12, 2022.
Support at the live event was provided by
The Foundation for Barnes-Jewish Hospital
Publication Date: May 3, 2023
Expiration Date: May 5, 2023
This presentation originated from the "Updates in Clinical Allergy & Immunology" course held August 12, 2022.
Support at the live event was provided by
The Foundation for Barnes-Jewish Hospital
Accreditation Information:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement:
Credit Awarded for this Activity:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 ANCC contact hour.
Accreditation Council for Pharmacy Education (ACPE)
This activity is approved for a maximum of 4.5 knowledge-based contact hours (.45 CEUs) in states that recognize ACPE. Participants should only claim credit commensurate with the extent of their participation in the activity. Unique Universal Activity Number JA0000340-0000-22-006-L01-P. To be awarded credit, attendees must sign in, provide their NABP ePID number and date of birth.
American Board of Pediatrics' Maintenance of Certificate Program (ABP MOC II)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 4.5 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Internal Medicine Maintenance of Certification (ABIM MOC II)
Successful completion of the CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Credit.
Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credits for learning and change.
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 ANCC contact hour.
Accreditation Council for Pharmacy Education (ACPE)
This activity is approved for a maximum of 4.5 knowledge-based contact hours (.45 CEUs) in states that recognize ACPE. Participants should only claim credit commensurate with the extent of their participation in the activity. Unique Universal Activity Number JA0000340-0000-22-006-L01-P. To be awarded credit, attendees must sign in, provide their NABP ePID number and date of birth.
American Board of Pediatrics' Maintenance of Certificate Program (ABP MOC II)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 4.5 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Internal Medicine Maintenance of Certification (ABIM MOC II)
Successful completion of the CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Credit.
Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credits for learning and change.
References:
Israel E. Implementing the guidelines: what do you do when the rubber hits the road? J Allergy Clin Immunol 2020;146:1271-4.
Lazarinis et al. Combination of budesonide/formoterol on demand improves asthma control by reducing exercise induced bronchoconstriction. Thorax 2014;69:130-136
O'Byrne et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129-36.
Patel M et al. Efficacy and safety of maintenance and reliever combination budesonide=formoterol inhaler in patients a=with asthma t risk of severe exacerbations: a randomized controlled trial. Lancet Respir Med 2013;1:32-42
Sovani MP et al. Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? Br J Gen Pract. 2008 Jan;58(546):37-43.
Lazarinis et al. Combination of budesonide/formoterol on demand improves asthma control by reducing exercise induced bronchoconstriction. Thorax 2014;69:130-136
O'Byrne et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129-36.
Patel M et al. Efficacy and safety of maintenance and reliever combination budesonide=formoterol inhaler in patients a=with asthma t risk of severe exacerbations: a randomized controlled trial. Lancet Respir Med 2013;1:32-42
Sovani MP et al. Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? Br J Gen Pract. 2008 Jan;58(546):37-43.
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
All members of the CME department have nothing to disclose.
Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.
These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the sponsor for CME credits.
This course is intended for healthcare professionals only. Continuing Medical Education at Washington University School of Medicine fully complies with the legal requirements of the Americans with Disabilities Act rules and regulations thereof. If any participant of this course is in need of accommodations, please contact us at cme@wustl.edu.
All members of the CME department have nothing to disclose.
Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.
These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the sponsor for CME credits.
Category:
Medicine
Accreditation
AMA: 0.75
ANCC: 0.75
Attendance: 0.75
IPCE: 0.75
